Quantcast
Channel: REGULATORY AND MARKETPLACE v5 I4 – IPI International Pharmaceutical Industry
Viewing all articles
Browse latest Browse all 4

Adaptive Licensing – Maximising Value

$
0
0

Adaptive licensing is currently being promoted as a means for earlier patient access to novel drugs. However, there is a high level of uncertainty regarding the current regulatory feasibility of certain adaptive licensing strategies and the potential commercial advantages of such strategies. Daniel Lewinski and Christian Elze at Catenion explains the current EU and US regulatory frameworks and a methodology to assess the commercial implications of adaptive licensing strategies.

The post Adaptive Licensing – Maximising Value appeared first on IPI International Pharmaceutical Industry.


Viewing all articles
Browse latest Browse all 4

Trending Articles